1. Home
  2. MYSE vs BGLC Comparison

MYSE vs BGLC Comparison

Compare MYSE & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Myseum Inc.

MYSE

Myseum Inc.

HOLD

Current Price

$1.76

Market Cap

8.7M

ML Signal

HOLD

Logo BioNexus Gene Lab Corp

BGLC

BioNexus Gene Lab Corp

HOLD

Current Price

$3.55

Market Cap

10.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYSE
BGLC
Founded
2014
2017
Country
United States
Malaysia
Employees
N/A
N/A
Industry
Telecommunications Equipment
Medical Specialities
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.7M
10.1M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
MYSE
BGLC
Price
$1.76
$3.55
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
39.5K
10.2K
Earning Date
11-13-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$581.00
$9,465,006.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
12.82
2.21
52 Week Low
$1.63
$2.01
52 Week High
$6.02
$15.60

Technical Indicators

Market Signals
Indicator
MYSE
BGLC
Relative Strength Index (RSI) 42.80 22.37
Support Level $1.71 $3.69
Resistance Level $1.98 $3.89
Average True Range (ATR) 0.16 0.20
MACD -0.00 -0.05
Stochastic Oscillator 31.03 1.63

Price Performance

Historical Comparison
MYSE
BGLC

About MYSE Myseum Inc.

Myseum Inc is a blockchain, cybersecurity, and social media company that not only focuses on protecting privacy on personal devices, but also protects user information after it is shared with others. Its mobile messaging application is called DatChat Messenger which is a free messaging application. The platform allows users to exercise control over their messages and posts.

About BGLC BioNexus Gene Lab Corp

BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.

Share on Social Networks: